X-154031127-G-C

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BS2BA1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ala234Gly variant in MECP2 (NM_004992.3) is 0.26% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ala234Gly variant is observed in at least 2 unaffected individuals (internal database) (BS2). In summary, the p.Ala234Gly variant in MECP2 is classified as Benign based on the ACMG/AMP criteria (BA1, BS2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA294719/MONDO:0010726/016

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000058 ( 0 hom. 23 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
6
10

Clinical Significance

Benign reviewed by expert panel U:2B:5

Conservation

PhyloP100: 1.56
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.737C>G p.Ala246Gly missense_variant 3/3 ENST00000453960.7 NP_001104262.1
MECP2NM_004992.4 linkuse as main transcriptc.701C>G p.Ala234Gly missense_variant 4/4 ENST00000303391.11 NP_004983.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.737C>G p.Ala246Gly missense_variant 3/31 NM_001110792.2 ENSP00000395535 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.701C>G p.Ala234Gly missense_variant 4/41 NM_004992.4 ENSP00000301948 P1P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000542
AC:
6
AN:
110702
Hom.:
0
Cov.:
23
AF XY:
0.0000303
AC XY:
1
AN XY:
33010
show subpopulations
Gnomad AFR
AF:
0.0000660
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000761
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000379
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000125
AC:
23
AN:
183356
Hom.:
0
AF XY:
0.000118
AC XY:
8
AN XY:
67854
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00267
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.0000583
AC:
64
AN:
1098226
Hom.:
0
Cov.:
36
AF XY:
0.0000633
AC XY:
23
AN XY:
363580
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00232
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000131
Gnomad4 OTH exome
AF:
0.000174
GnomAD4 genome
AF:
0.0000542
AC:
6
AN:
110702
Hom.:
0
Cov.:
23
AF XY:
0.0000303
AC XY:
1
AN XY:
33010
show subpopulations
Gnomad4 AFR
AF:
0.0000660
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000761
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000379
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000227
Hom.:
6
Bravo
AF:
0.0000604
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 27, 2014- -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 21, 2020- -
Rett syndrome Benign:1
Benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelDec 08, 2022The allele frequency of the p.Ala234Gly variant in MECP2 (NM_004992.3) is 0.26% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ala234Gly variant is observed in at least 2 unaffected individuals (internal database) (BS2). In summary, the p.Ala234Gly variant in MECP2 is classified as Benign based on the ACMG/AMP criteria (BA1, BS2). -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 07, 2017This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
MECP2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 31, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Uncertain
0.025
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.31
T;.;T;T
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.79
T;T;T;T
M_CAP
Pathogenic
0.60
D
MetaRNN
Benign
0.043
T;T;T;T
MetaSVM
Uncertain
-0.071
T
MutationAssessor
Benign
1.4
L;.;.;.
MutationTaster
Benign
0.72
D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.48
N;N;.;.
REVEL
Uncertain
0.37
Sift
Benign
0.36
T;T;.;.
Sift4G
Benign
0.25
T;T;.;T
Polyphen
0.92
P;P;.;.
Vest4
0.092
MutPred
0.084
Gain of catalytic residue at P230 (P = 0.0924);.;Gain of catalytic residue at P230 (P = 0.0924);.;
MVP
0.97
ClinPred
0.12
T
GERP RS
4.6
Varity_R
0.067
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138211345; hg19: chrX-153296578; API